These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4263013)

  • 1. [Clinical evaluation of pyridostigmine bromide (Mestinon) as a curare-antagonist].
    Shima T; Hashimoto Y; Shiozawa S; Iwatsuki K
    Masui; 1972 May; 21(5):427-31. PubMed ID: 4263013
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridostigmin (mestinon) as an antagonist of d-tubocurarine.
    Katz RL
    Anesthesiology; 1967; 28(3):528-34. PubMed ID: 6023525
    [No Abstract]   [Full Text] [Related]  

  • 3. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45.
    Krieg N; Mazur L; Booij LH; Crul JF
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):423-5. PubMed ID: 6110303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new look at an old drug.
    Miller RD; Cronnelly R
    Anesthesiology; 1983 Aug; 59(2):84-5. PubMed ID: 6223543
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of pyridostigmine for the reversal of neuromuscular blockade.
    McNall PG; Wolfson B; Tuazon JG; Siker ES
    Anesth Analg; 1969; 48(6):1026-32. PubMed ID: 5391379
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative times to peak effect and durations of action of neostigmine and pyridostigmine.
    Miller RD; Van Nyhuis LS; Eger EI; Vitez TS; Way WL
    Anesthesiology; 1974 Jul; 41(1):27-33. PubMed ID: 4834375
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH; van der Pol F; Crul JF; Miller RD
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the actions of the neuromuscular blocking agent, dipyrandium iodide, on cardiovascular and respiratory function in the horse.
    Lees P; Tavernor WD
    Res Vet Sci; 1969 Sep; 10(5):428-34. PubMed ID: 4243172
    [No Abstract]   [Full Text] [Related]  

  • 9. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison between the hypertensive activity and anticholinesterase activity of neostigmine].
    Siro-Brigiani G; Chieppa D
    Arch Ital Sci Farmacol; 1965; 15(3):164-7. PubMed ID: 5877518
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamic effects of mestinon (dimethyl-carbamic acid ester of 3-hydroxy-1-methyl-pyridinum bromide).
    Kajimoto N
    Acta Sch Med Univ Kioto; 1970 Mar; 40(3):254-68. PubMed ID: 5447690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical studies on pyridostigmine as an antagonist of non-depolarizing blocking agents].
    Nakao H; Fukushima K
    Masui; 1976 Feb; 25(2):136-42. PubMed ID: 943598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine].
    Stoyanov M; Müller H; Lobisch M; Hempelmann G
    Anaesthesist; 1984 Oct; 33(10):499-503. PubMed ID: 6239562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neostigmine and pyridostigmine on serum cholinesterase activity.
    Mirakhur RK; Lavery TD; Briggs LP; Clarke RS
    Can Anaesth Soc J; 1982 Jan; 29(1):55-8. PubMed ID: 7055744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with pancuronium bromide in infants and children.
    Yamamoto T; Baba H; Shiratsuchi T
    Anesth Analg; 1972; 51(6):919-24. PubMed ID: 4264153
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report.
    Davis L; Jayarajah MJ; Toner CC; Flynn PJ
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():65-8. PubMed ID: 8557009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pipecuronium bromide: a new steroid muscle relaxant--a clinical study.
    Jasser MT
    Middle East J Anaesthesiol; 1995 Jun; 13(2):181-95. PubMed ID: 7476740
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical evaluation of pyridostigmine bromide in the reversal of pancuronium.
    Lippmann M; Rogoff RC
    Anesth Analg; 1974; 53(1):20-3. PubMed ID: 4855709
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical anesthesia and the cardiovascular system. International review].
    Dottori O
    Acta Anaesthesiol; 1969; 20(5):901-59. PubMed ID: 4394232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.